Browsing Tag

CytoReason

CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar…

Nick J Adam Jan 24, 2023

TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease…
Read More...

Pfizer extends collaboration with disease model co CytoReason

Nick J Adam Sep 23, 2022

Israeli company CytoReason, a developer of computational disease models that assist in the design of…
Read More...

Exit mobile version